Physician profile
Chad Brown
NPI 1598766933
$14,843.83
in general payments reported to CMS, 2019-2025
35 companies · $2,359 in 2025
The $2,359 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,816 · 2020: $1,583 · 2021: $1,964 · 2022: $2,303 · 2023: $2,505 · 2024: $2,314 · 2025: $2,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,995 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,994.92 |
| Education | $183.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,940.40 | 2019-2025 | Rinvoq, Skyrizi |
| Ucb, INC. | $1,955.99 | 2019-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $1,832.73 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,232.50 | 2019-2025 | |
| Lilly USA, LLC | $1,088.45 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $929.04 | 2019-2025 | Dupixent, Libtayo |
| Amgen INC. | $855.99 | 2020-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $680.38 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $592.28 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $443.96 | 2019-2025 | Blu-U, Odomzo, Winlevi |
| Pfizer INC. | $305.36 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $232.21 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $232.19 | 2019-2025 | Nemluvio, Aklief |
| Incyte Corporation | $210.85 | 2021-2024 | Opzelura |
| Leo Pharma INC. | $182.16 | 2019-2025 | Adbry, Anzupgo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $181.74 | 2022-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $142.26 | 2019-2023 | Jublia |
| Dermira, INC. | $137.88 | 2019-2021 | |
| Celgene Corporation | $112.45 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.70 | 2023-2024 | Spevigo, Cyltezo |
| Prugen, INC. Pharmaceuticals | $60.95 | 2019 | |
| Biofrontera INC. | $49.87 | 2021-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Merz North America, INC. | $49.47 | 2023-2025 | |
| Almirall LLC | $40.67 | 2021-2025 | Klisyri |
| Botanix Sb INC | $37.96 | 2025 | Sofdra |
| Mylan Institutional INC. | $34.26 | 2023 | Hulio |
| Mayne Pharma Commercial LLC | $33.31 | 2019-2020 | |
| Taro Pharmaceuticals USA, INC. | $32.23 | 2019 | |
| Fresenius Kabi USA, LLC | $29.40 | 2023 | Idacio |
| Epi Health, LLC | $21.74 | 2021 | |
| Vyne Pharmaceuticals INC. | $20.63 | 2021 | |
| Sandoz INC. | $19.14 | 2024 | Hyrimoz |
| Boston Scientific Corporation | $17.10 | 2022 | |
| Encore Dermatology INC. | $16.10 | 2020 | |
| Alpha Orthopedic Systems | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.